Sun Pharmaceutical Industries Ltd. - Research Center
524715 SUNPHARMA Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Mar ' 21 |
Sales |
9,562.28 |
10,218.17 |
7,777.54 |
7,808.44 |
6,547.66 |
Operating profit |
2,335.08 |
3,112.83 |
1,656.23 |
1,251.29 |
1,426.49 |
Interest |
351.57 |
179.84 |
176.66 |
211.44 |
174.66 |
Gross profit |
2,253.59 |
3,023.69 |
2,085.21 |
1,392.13 |
1,307.68 |
EPS (Rs) |
5.29 |
9.27 |
-3.21 |
2.80 |
3.68 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Mar ' 21 |
Other income |
270.08 |
90.70 |
605.64 |
352.28 |
55.85 |
Stock adjustment |
81.16 |
-95.63 |
-175.23 |
-7.95 |
-64.08 |
Raw material |
2,251.87 |
2,727.01 |
2,413.29 |
2,171.68 |
1,956.97 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
1,207.85 |
1,101.66 |
999.73 |
1,001.05 |
880.10 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
3,686.32 |
3,372.30 |
2,883.52 |
3,392.37 |
2,348.18 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
807.98 |
758.45 |
709.38 |
640.57 |
298.65 |
Taxation |
27.13 |
40.43 |
491.65 |
-84.80 |
36.53 |
Net profit / loss |
1,269.27 |
2,224.81 |
-770.78 |
670.79 |
882.94 |
Extra ordinary item |
-149.21 |
- |
-1,654.96 |
-165.57 |
-89.56 |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
239.93 |
239.93 |
239.93 |
239.93 |
239.93 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
24.42 |
30.46 |
21.30 |
16.02 |
21.79 |
GPM (%) |
22.92 |
29.33 |
24.87 |
17.06 |
19.80 |
NPM (%) |
12.91 |
21.58 |
-9.19 |
8.22 |
13.37 |